Securities Code: 002950 Securities Abbreviation: Aomei Medical Announcement Number: 2026-023 Aomei Medical Products Co., Ltd. Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
I. Convening of the Board Meeting
The fifth meeting of the fourth Board of Directors of Aomei Medical Products Co., Ltd. (hereinafter referred to as the "Company") was held on June 17, 2026 (Wednesday) in the fifth-floor conference room of Aomei Medical Products Co., Ltd., No. 18, Qixing Avenue, Majiadian, Zhijiang City, Hubei Province, through on-site and remote communication methods. The meeting notice was delivered to all directors via email on June 14, 2026. Nine directors were expected to attend, and nine directors actually attended.
The meeting was presided over by Chairman Cui Jinhai, and some senior management personnel attended the meeting. The convening of the meeting complied with relevant laws, regulations, rules, and the "Articles of Association." After careful deliberation by all directors, the meeting formed the following resolutions:
II. Deliberation of the Board Meeting
(I) Deliberation and Approval of the "Proposal on the <2026 Employee Stock Ownership Plan (Draft)> and its Summary"